Case analysis of clinical pharmacist participating in the therapy of cryptogenic organizing pneumonia

Abstract

Abstract: AIM: To discuss how clinical pharmacist involved in infection medication. METHODS: The drug treatment of 1 patient with cryptogenic organizing pneumonia was analyzed. RESULTS: Clinical pharmacist analyzed the causes of fever according to the patient's condition and the reasons for poor control of blood pressure, and established medication monitoring program to solve the problems. CONCLUSION: The clinical pharmacists establishes medication monitoring points, and playes pharmacy professional skills to ensure the safety and health for the people.

Key words: clinical pharmacist, cryptogenic organizing pneumonia, case analysis

CLC Number:

R969.1

YUE Hui-jie, TAO Ying-ying, SONG Xiao-jun. Case analysis of clinical pharmacist participating in the therapy of cryptogenic organizing pneumonia[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(12): 1361-1364.

[1]	ZHANG Zhaowei, LI Zuojun, HUANG Jian, LI Shuangqing, HE YiLin. Exploring the outbreak point for clinical pharmacists to provide pharmaceutical care in nephrology department [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 184-188.
[2]	YU Yahong, SONG Yu. Pharmacotherapy of patients with left ventricular assist devices [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 198-204.
[3]	ZHOU Haihui, ZHANG Haixia, GE Weihong. Analysis of the role of clinical pharmacist in the establishment of standardized cancer pain management ward [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 1038-1042.
[4]	YANG Rui, LIU Hui, CHEN Zeheng, QI Tingting，ZHANG Zanling, QU Qiang. Clinical pharmacists use CYP2C19 genotyping test to guide individual medication therapy of Clopidogrel and to evaluate the efficacy of treatment [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(8): 938-943.
[5]	YUAN Yumei, WANG Ronghua, YANG Shuixin. Pharmaceutical service in statinsinduced Rhabdomyolysis by clinical pharmacists [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(6): 704-708.
[6]	ZHU Xuting, HANG Yongfu. Clinical pharmacists' pharmaceutical care and practice in the department of nephrology [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(10): 1174-1178.
[7]	LI Nan，HUANG Haitao，YONG Xiaolan. Pharmaceutical care for a patient misdiagnosed as Staphylococcus intermedius pulmonary infection [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(9): 1067-1071.
[8]	DANG Xiangji, ZHOU Lin, WANG Yixuan, ZENG Lu. Individualized antithrombotic therapy on one patient with chronic renal insufficiency [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(4): 477-480.
[9]	YU Yang, HE Jiake, XIONG Aizhen, DING Nan. Role of clinical pharmacists in the anti-infective therapy after anterior cruciate ligament reconstructions: an individualized medicine perspective [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(2): 194-197.
[10]	ZHANG Wen, WANG Lin, XU Wen-ke. Effects of examining prescriptions on rational application of antibiotics in diabetes patients combined with urinary tract infection [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(4): 420-424.
[11]	WANG Yu, HU Xiao-lei, TANG Min. Pharmaceutical care for clinical therapy in a patient with bacteremia [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(4): 415-418.
[12]	LIN Qi, DAI Wen-sen, GUO Li-jing. Approaches for clinical pharmacists to implement pharmaceutical care for bronchiectasis patients [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(11): 1238-1240.
[13]	SHAN Jiao-jiao,TANG Yi-qun,SHI Mei-qi, XIA Guo-hao, WANG Li,FANG Ying,ZHAO Jie. Impact of clinical pharmacists on protocol deviation in anti-cancer drug clinical trial [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(1): 33-37.
[14]	LUO Song-mei, YE Wei-hong, HUA Jun-yan. Clinical pharmacists' participation in acute exacerbations of COPD therapy practice [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(9): 1014-1018.
[15]	ZHU Su-yan, HU Yi-jian. Pharmacists' practice in carrying out typical cases of adverse drug reaction identification [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(8): 906-909.

Case analysis of clinical pharmacist participating in the therapy of cryptogenic organizing pneumonia

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments